These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tick anticoagulant peptide: kinetic analysis of the recombinant inhibitor with blood coagulation factor Xa. Jordan SP, Waxman L, Smith DE, Vlasuk GP. Biochemistry; 1990 Dec 18; 29(50):11095-100. PubMed ID: 2271697 [Abstract] [Full Text] [Related]
4. Kinetics of factor Xa inhibition by recombinant tick anticoagulant peptide: both active site and exosite interactions are required for a slow- and tight-binding inhibition mechanism. Rezaie AR. Biochemistry; 2004 Mar 30; 43(12):3368-75. PubMed ID: 15035608 [Abstract] [Full Text] [Related]
6. Site-directed analysis of the functional domains in the factor Xa inhibitor tick anticoagulant peptide: identification of two distinct regions that constitute the enzyme recognition sites. Dunwiddie CT, Neeper MP, Nutt EM, Waxman L, Smith DE, Hofmann KJ, Lumma PK, Garsky VM, Vlasuk GP. Biochemistry; 1992 Dec 08; 31(48):12126-31. PubMed ID: 1457408 [Abstract] [Full Text] [Related]
12. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Maraganore JM, Bourdon P, Jablonski J, Ramachandran KL, Fenton JW. Biochemistry; 1990 Jul 31; 29(30):7095-101. PubMed ID: 2223763 [Abstract] [Full Text] [Related]
13. Ecotin is a potent anticoagulant and reversible tight-binding inhibitor of factor Xa. Seymour JL, Lindquist RN, Dennis MS, Moffat B, Yansura D, Reilly D, Wessinger ME, Lazarus RA. Biochemistry; 1994 Apr 05; 33(13):3949-58. PubMed ID: 8142399 [Abstract] [Full Text] [Related]
14. A new peptide (Ruviprase) purified from the venom of Daboia russelii russelii shows potent anticoagulant activity via non-enzymatic inhibition of thrombin and factor Xa. Thakur R, Kumar A, Bose B, Panda D, Saikia D, Chattopadhyay P, Mukherjee AK. Biochimie; 2014 Oct 05; 105():149-58. PubMed ID: 25038567 [Abstract] [Full Text] [Related]
15. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va. Heeb MJ, Kojima Y, Hackeng TM, Griffin JH. Protein Sci; 1996 Sep 05; 5(9):1883-9. PubMed ID: 8880912 [Abstract] [Full Text] [Related]
16. Characterization of recombinant tick anticoagulant peptide. A highly selective inhibitor of blood coagulation factor Xa. Neeper MP, Waxman L, Smith DE, Schulman CA, Sardana M, Ellis RW, Schaffer LW, Siegl PK, Vlasuk GP. J Biol Chem; 1990 Oct 15; 265(29):17746-52. PubMed ID: 2211658 [Abstract] [Full Text] [Related]
18. Expression and purification of recombinant tick anticoagulant peptide (Y1W/D10R) double mutant secreted by Saccharomyces cerevisiae. Cook JC, Schultz LD, Huang J, George HA, Herber WK, Ip C, Joyce JG, Mao SS, Markus HZ, Miller WJ, Sardana MK, Lehman ED. Protein Expr Purif; 1998 Aug 15; 13(3):291-300. PubMed ID: 9693053 [Abstract] [Full Text] [Related]
19. Assembly of the prothrombinase complex enhances the inhibition of bovine factor Xa by tick anticoagulant peptide. Krishnaswamy S, Vlasuk GP, Bergum PW. Biochemistry; 1994 Jun 28; 33(25):7897-907. PubMed ID: 8011652 [Abstract] [Full Text] [Related]
20. Site-directed mutagenesis of the leech-derived factor Xa inhibitor antistasin. Probing of the reactive site. Hofmann KJ, Nutt EM, Dunwiddie CT. Biochem J; 1992 Nov 01; 287 ( Pt 3)(Pt 3):943-9. PubMed ID: 1445252 [Abstract] [Full Text] [Related] Page: [Next] [New Search]